Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
An. bras. dermatol ; 91(5): 595-600, Sept.-Oct. 2016. graf
Article in English | LILACS | ID: biblio-827746

ABSTRACT

Abstract: Background: Heparanase is an enzyme that cleaves heparan sulfate chains. Oligosaccharides generated by heparanase induce tumor progression. Basal cell carcinoma and squamous cell carcinoma comprise types of nonmelanoma skin cancer. Objectives: Evaluate the glycosaminoglycans profile and expression of heparanase in two human cell lines established in culture, immortalized skin keratinocyte (HaCaT) and squamous cell carcinoma (A431) and also investigate the expression of heparanase in basal cell carcinoma, squamous cell carcinoma and eyelid skin of individuals not affected by the disease (control). Methods: Glycosaminoglycans were quantified by electrophoresis and indirect ELISA method. The heparanase expression was analyzed by quantitative RT-PCR (qRTPCR). Results: The A431 strain showed significant increase in the sulfated glycosaminoglycans, increased heparanase expression and decreased hyaluronic acid, comparing to the HaCaT lineage. The mRNA expression of heparanase was significantly higher in Basal cell carcinoma and squamous cell carcinoma compared with control skin samples. It was also observed increased heparanase expression in squamous cell carcinoma compared to the Basal cell carcinoma. Conclusion: The glycosaminoglycans profile, as well as heparanase expression are different between HaCaT and A431 cell lines. The increased expression of heparanase in Basal cell carcinoma and squamous cell carcinoma suggests that this enzyme could be a marker for the diagnosis of such types of non-melanoma cancers, and may be useful as a target molecule for future alternative treatment.


Subject(s)
Humans , Skin Neoplasms/enzymology , Carcinoma, Basal Cell/enzymology , Carcinoma, Squamous Cell/enzymology , Glucuronidase/metabolism , Glycosaminoglycans/metabolism , RNA, Messenger/metabolism , Keratinocytes/metabolism , Eyelids/enzymology , Real-Time Polymerase Chain Reaction/methods , Glucuronidase/genetics , Glycosaminoglycans/analysis , Hyaluronic Acid/analysis , Hyaluronic Acid/metabolism
2.
Invest. clín ; 57(1): 59-65, mar. 2016. ilus
Article in Spanish | LILACS | ID: biblio-841099

ABSTRACT

Se presenta un varón de 56 años con un leiomioma atípico en el contexto de una leiomiomatosis cutánea, con antecedentes familiares de miomatosis uterina y con estudio genético que revela una mutación en el gen de la enzima fumarato hidratasa, sin que hasta el momento presente ningún tipo de neoplasia maligna renal. El leiomioma atípico es un tumor poco frecuente, que usualmente ocurre de forma aislada, siendo excepcional la presentación en pacientes con leiomiomatosis cutánea. Es ampliamente conocida la relación de la mutación de la enzima fumarato hidratasa con leiomiomas mútiples, miomas uterinos y el mayor riesgo de desarrollar cáncer renal; sin embargo, el papel de esta mutación en el desarrollo de leiomiomas atípicos es por hoy imposible de esclarecer debido a los escasos casos recogidos en la literatura.


We report the case of a 56 year-old male with an atypical leiomyoma in the context of a cutaneous leiomyomatosis and a family history of uterine leiomyomatosis. The genetic study revealed a mutation in the gene for the enzyme fumarate hydratase, but he has not had any renal malignancy so far. Atypical leiomyoma is a rare tumor that usually presents as a single lesion and is exceptional in patients with cutaneous leiomyomatosis. The relation between fumarate hydratase enzyme mutations with multiple leiomyomas, uterine leiomyomatosis and an increased risk of developing kidney cancer is widely known. However, the role of these mutations in the development of atypical leiomyomas is still impossible to clarify given the few cases reported in the literature.


Subject(s)
Humans , Male , Middle Aged , Skin Neoplasms/genetics , Leiomyomatosis/genetics , Fumarate Hydratase/genetics , Mutation , Skin Neoplasms/enzymology , Skin Neoplasms/pathology , Leiomyomatosis/enzymology , Leiomyomatosis/pathology , Leiomyoma/enzymology , Leiomyoma/genetics , Leiomyoma/pathology
3.
Acta cir. bras ; 27(12): 855-860, dez. 2012. graf
Article in English | LILACS | ID: lil-657968

ABSTRACT

PURPOSE: To evaluate telomerase activity and proliferation of HS839.T melanoma cells, subjected to the action of AZT. METHODS: Cells were grown in triplicate, AZT at different concentrations: 50, 100 and 200μM, was added and left for 24 and 48 hours, and its effects were compared with the control group. Telomerase activity was detected by PCR and cell proliferation was evaluated by MTT. RESULTS: After 24 hours, there was no inhibition of cell proliferation or telomerase activity when compared to the control group. After 48 hours, there was a momentary decrease, suggesting that the cell lines used in this study are sensitive to AZT, but quickly recover both the enzyme activity and cell proliferation. CONCLUSION: The action of AZT on the melanoma cells studied, at the concentrations and times tested, did not inhibit telomerase activity nor affect cell proliferation.


OBJETIVO: Avaliar a atividade da telomerase e da proliferação de células de melanoma HS839.T submetidas à ação do AZT. MÉTODOS: As células foram cultivadas, em triplicata, com diferentes concentrações de AZT: 50, 100 e 200µM, por 24h e 48h, seus efeitos comparados com o grupo controle. A atividade da telomerase foi detectada por PCR e a proliferação celular avaliada por MTT. RESULTADOS: No tempo de 24 horas, não houve inibição da proliferação celular e da atividade da telomerase em comparação com o grupo controle. No período de 48 horas, houve uma diminuição momentânea, sugerindo que as células das linhagens utilizadas neste estudo são sensíveis ao AZT, mas que recuperam a atividade enzimática e proliferativa. CONCLUSÃO: Nas células de melanoma HS839.T estudadas e nas concentrações e tempos propostos, a ação do AZT não inibiu a atividade da telomerase e não afetou a proliferação celular.


Subject(s)
Adult , Female , Humans , Cell Proliferation/drug effects , Melanoma/pathology , Skin Neoplasms/pathology , Telomerase/metabolism , Zidovudine/pharmacology , Cell Line, Tumor , Dose-Response Relationship, Drug , Melanoma/enzymology , Skin Neoplasms/enzymology , Time Factors , Telomerase/antagonists & inhibitors , Zidovudine/administration & dosage
4.
Clinics ; 67(3): 237-241, 2012. tab
Article in English | LILACS | ID: lil-623097

ABSTRACT

OBJECTIVE: Isolated limb perfusion combined with melphalan is an accepted treatment for obtaining locoregional control in advanced melanoma of the extremities and other malignant neoplasias restricted to the limb. This study aims to examine the factors associated with toxicity caused by the regional method. We considered the technical aspects of severe complications associated with the procedure in an attempt to diminish the patient morbidity that occurs during the learning curve. METHODS: We conducted a retrospective analysis of the records of patients who underwent perfusion at the AC Camargo Hospital in São Paulo, Brazil between January 2000 and January 2009. The Wieberdink scale was applied to classify local toxicity and its relation to clinical and laboratory variables. RESULTS: Fifty-eight perfusions were performed in 55 patients. Most patients (86.2%) presented a toxicity level between I and III. Grade V toxicity was seen in five cases (8.6%), four of which occurred in the first 2 years. Creatine phosphokinase, an important predictive factor for toxicity, had an average value of 231.8 for toxicity grades I-III and 1286.2 for toxicity grades IV-V (p = 0.001). There was a relationship between the melphalan dose and toxicity, which was 77 mg (25 to 130 mg) for toxicity grades I-II and 93.5 mg (45 to 120 mg) for toxicity grades IV-V (p = 0.0204). CONCLUSION: It is possible to prevent the toxicity associated with melphalan by adjusting the dose according to the patient's body weight (especially for women and obese patients) and the creatine phosphokinase values in the postoperative period.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Antineoplastic Agents, Alkylating/adverse effects , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Body Weight/physiology , Chemotherapy, Cancer, Regional Perfusion/adverse effects , Leg , Melanoma/drug therapy , Melphalan/adverse effects , Skin Neoplasms/drug therapy , Antineoplastic Agents, Alkylating/administration & dosage , Chemotherapy, Cancer, Regional Perfusion/methods , Creatine Kinase/blood , Drug Dosage Calculations , Melanoma/enzymology , Melphalan/administration & dosage , Retrospective Studies , Risk Factors , Statistics, Nonparametric , Skin Neoplasms/enzymology
5.
J. bras. patol. med. lab ; 44(2): 115-121, abr. 2008. ilus, graf, tab
Article in Portuguese | LILACS | ID: lil-486033

ABSTRACT

INTRODUÇÃO: Aproximadamente 80 por cento das neoplasias malignas de pele não-melanomas são carcinomas basocelulares (CBC). Apesar das raras metástases, esses tumores são localmente agressivos. As metaloproteinases de matriz (MMPs), especialmente as MMP-2 e 9, são importantes no processo de invasão. Em contrapartida, os inibidores teciduais das MMPs (TIMPs) têm como principal função a inibição dessas enzimas. OBJETIVO: Investigar a associação de variáveis clinicopatológicas de pacientes portadores de CBC com a expressão de MMP-2, MMP-9, TIMP-1 e TIMP-2. MATERIAL E MÉTODOS: Foram selecionados 31 casos de CBC, sendo então obtidos, retrospectivamente, os dados referentes a idade, sexo e tamanho da lesão. Cortes histológicos das lesões foram submetidos a reação imuno-histoquímica pela técnica estreptavidina-biotina-peroxidase para detecção dos antígenos de interesse. Índices de imunomarcação foram construídos e comparados com os dados previamente obtidos. RESULTADOS: Observou-se correlação significativa entre idade e tamanho da lesão (R = 0,532; p = 0,008). Não foram observadas correlações significativas entre as outras variáveis e a expressão imuno-histoquímica dos antígenos de interesse. CONCLUSÃO: A expressão das metaloproteinases e de seus inibidores teciduais não parece ser influenciada pelos parâmetros investigados. Estudos adicionais são necessários para melhor compreensão de sua associação com o comportamento biológico do CBC.


INTRODUCTION: Approximately 80 percent of non-melanoma skin neoplasias are basal cell carcinomas (BCC). Although metastasis is rare, BBC carcinomas are locally aggressive tumors. Matrix metalloproteinases (MMPs), mainly MMP-2 and MMP-9, play an important role on the invasion process. On the other hand, tissue inhibitors of MMPs (TIMPs) have the main function of inhibiting these enzymes. OBJECTIVE: To investigate the association of clinical-pathological variables of BCC patients with the expression of MMP-2 and MMP-9, TIMP-1 and TIMP-2. Methods: Thirty-one BCC cases were selected. Gender, age of the patients and size of the lesions were obtained retrospectively. Histological cuts of the lesions were exposed to immunohistochemistry reaction by use of the streptavidine-biotin peroxidase technique in order to detect antigens. Immunomarking parameters were established and compared with previous data. RESULTS: A significant correlation between age and size of the lesion was observed (R = 0.532; p = 0.008). No significant correlations between other variables and immunohistochemical expression of antigens were observed. CONCLUSION: The expression of MMPs and TIMPs does not seem to be influenced by the parameters investigated in this work. Additional studies should be made to better understand its association with the biological behavior of basal cell carcinomas.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged, 80 and over , Carcinoma, Basal Cell/diagnosis , Carcinoma, Basal Cell/enzymology , Tissue Inhibitor of Metalloproteinase-1/analysis , /analysis , Matrix Metalloproteinase 9/analysis , /analysis , Matrix Metalloproteinases/analysis , Skin Neoplasms/enzymology , Age and Sex Distribution , Immunohistochemistry , Neoplasm Invasiveness/diagnosis , Biomarkers, Tumor/metabolism , Skin Neoplasms/metabolism
6.
Article in English | IMSEAR | ID: sea-37602

ABSTRACT

The methylthioadenosine phosphorylase (MTAP) gene is a tumour suppressor gene, located on chromosome 9p21, 100 kb telomeric of the p15 and p16 genes, which are often deleted in tumor cells. The role of MTAP protein expression in the genesis of cutaneous squamous cell carcinoma (SCC) is currently not known. In a previous study we have shown the frequent occurrence of allelic imbalance/loss of heterozygosity (AI/LOH) in cutaneous SCCs using AI/LOH markers flanking the p15, p16, and MTAP genes and demonstrated reduction in p15 and p16 protein expression in comparison to normal human skin. The present study is a continuation to our previous studies, aimed at determining possible roles played by MTAP protein expression in the genesis of cutaneous SCC. The expression of MTAP protein was detected using immunohistochemical approach in 109 micro array cutaneous SCC and 20 normal human skin tissue samples. The expression of MTAP was not significantly different in the cutaneous SCC cases as compared with normal human skin. This may indicate that MTAP protein expression does not contribute to the genesis of cutaneous SCC.


Subject(s)
Carcinoma, Squamous Cell/enzymology , Case-Control Studies , Humans , Immunoenzyme Techniques , Purine-Nucleoside Phosphorylase/metabolism , Skin/enzymology , Skin Neoplasms/enzymology , Tissue Array Analysis
7.
Journal of Korean Medical Science ; : 302-306, 2008.
Article in English | WPRIM | ID: wpr-173549

ABSTRACT

In a previous search for the differentially expressed genes in keratinocyte differentiation, we identified neutrophil gelatinase-associated lipocalin (NGAL) as a calcium- induced gene. In this study, we further verified the expression of NGAL in cultured keratinocytes as well as in several skin diseases. Reverse transcription-polymerase chain reaction (RT-PCR), Western blot, and ELISA clearly showed that NGAL expression was markedly increased in calcium-induced keratinocyte differentiation in vitro. However, in our previous report, NGAL expression was not detected in normal skin tissue except for hair follicle by in situ hybridization and immunohistochemistry, indicating the difference of cell status between in vitro and in vitro conditions. Interestingly, NGAL expression was highly increased in psoriasis-like inflammatory disorders (lichen planus and pityriasis rubura pilaris) and skin cancers (keratoacanthoma and squamous cell carcinoma), implying that NGAL may be related with the epidermal hyperplasia. Collectively, these results reveal the potential importance of NGAL in the maintenance of skin homeostasis.


Subject(s)
Humans , Acute-Phase Proteins/biosynthesis , Calcium/metabolism , Cell Differentiation , Culture Media , Culture Media, Conditioned , Enzyme-Linked Immunosorbent Assay , Gene Expression Regulation , Homeostasis , Keratinocytes/enzymology , Lipocalins/biosynthesis , Models, Biological , Proto-Oncogene Proteins/biosynthesis , Psoriasis/enzymology , Reverse Transcriptase Polymerase Chain Reaction , Skin/metabolism , Skin Neoplasms/enzymology
8.
Rev. méd. Chile ; 135(3): 301-306, mar. 2007. tab
Article in English | LILACS | ID: lil-456615

ABSTRACT

Background: The identification of groups at high risk is fundamental to determine preventive strategies for skin cancer. Destructive reactive oxygen species produced by UVA or chemical carcinogens are metabolized by a series of enzymes. Polymorphisms of genes encoding for these enzymes may produce defective proteins with a diminished ability to detoxify a wide range of carcinogens. Aims: To ascertain the influence and potential interactions of several polymorphisms of genes encoding four important antioxidant GST enzymes in the susceptibility to cancer among Brazilians. Material and methods: We compared the genotypes of Glutathione S-Transferase mu, theta, pi and omega (GSTM1, GSTT1, GSTP1 and GSTO2) in a group of 102 patients with skin lesions and 124 controls. Results: Patients with Basal Cell Skin Carcinoma (BCC) presented the combined GSTM1-GSTT1+ genotype more frequently (49.1 percent) than controls (29.8 percent) (Fisher test; p =0.04), conferring a 2.273 (Odds Ratio; 95 percent CI =1.199-4.308) higher risk for BCC. We were not able to find any other association between genotypes or between any genotype and the patients' clinical features. Conclusions: The GST profile may help identify Brazilian individuals at higher risk for BCC.


Antecedentes: La identificación de grupos en riesgo elevado es fundamental en la determinación de las estrategias preventivas para el cáncer de la piel, el maligno humano más común. Las especies reactivas destructivas del oxígeno producidas por UVA o los agentes carcinógenos químicos son metabolizadas por una serie de enzimas. Los polimorfismos de los genes que codifican para estas enzimas pueden producir las enzimas defectuosas con una capacidad disminuida de desintoxicar una amplia gama de agentes carcinógenos. Objetivo: Este estudio fue diseñado para comprobar las interacciones de la influencia y del potencial de varios polimorfismos de los genes que codificaban 4 enzimas importantes del antioxidante GST en la susceptibilidad al cáncer entre brasileños. Métodos: Comparamos los genotipos del mu del S-Transferase del Glutathione, de la theta, de pi y de Omega (GSTM1, GSTT1, GSTP1 y GSTO2) en un grupo de 102 lesiones de piel y de 124 controles. Resultados: Los pacientes con el carcinoma basocelular (BCC) presentaron el genotipo combinado de GSTM1-GSTT1+ más frecuente (49,1 por ciento) que los controles (29,8 por ciento) (Fisher test; p =0,04), confiriendo 2.273 (Odds Ratio 95 por ciento CI =1.199-4.308) un riesgo más alto para BCC. No encontramos ninguna otra asociación entre los genotipos o entre ningún genotipo y características clínicas de los pacientes. Conclusiones: Sugerimos que el perfil de GST pueda ayudar a identificar a individuos brasileños en un riesgo más alto para BCC.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Carcinoma, Basal Cell/genetics , Genetic Predisposition to Disease/genetics , Glutathione Transferase/genetics , Polymorphism, Genetic/genetics , Skin Neoplasms/genetics , Carcinoma, Basal Cell/enzymology , Epidemiologic Methods , Genotype , Glutathione S-Transferase pi/genetics , Polymorphism, Restriction Fragment Length , Reactive Oxygen Species/metabolism , Skin Neoplasms/enzymology
9.
Indian J Exp Biol ; 2003 Dec; 41(12): 1416-23
Article in English | IMSEAR | ID: sea-60535

ABSTRACT

Chemopreventive potential of H. indicus on 7,12-dimethyl-benz[a]anthracene (DMBA)-initiated and 12-O-tetradecanoyl 13-phorbol acetate (TPA) promoted murine skin carcinogenesis has been assessed. Topical application of H. indicus resulted in significant protection against cutaneous tumorigenesis. Topical application of plant extract prior to that of TPA resulted in significant inhibition against TPA-caused induction of epidermal ornithine decarboxylase (ODC) activity and DNA synthesis. Application of H. indicus at a dose level of 1.5 and 3.0 mg/kg body weight in acetone prior to that of TPA treatment resulted in significant inhibition of oxidative stress. The level of lipid peroxidation was significantly reduced. In addition, depleted levels of glutathione and reduced activities of antioxidant enzymes were restored respectively). The results indicate that H. indicus is a potent chemopreventive agent in skin carcinogenesis.


Subject(s)
Animals , Carcinogens/toxicity , Catalase/metabolism , DNA/biosynthesis , Glutathione Peroxidase/metabolism , Glutathione Transferase/metabolism , Hemidesmus , Lipid Peroxidation , Mice , Oxidative Stress , Skin/enzymology , Skin Neoplasms/enzymology
10.
Rev. cuba. med. mil ; 24(2): 109-14, jul.-dic. 1995. ilus, tab
Article in Spanish | LILACS | ID: lil-168896

ABSTRACT

Se realizo un estudio inmunohistologico con anticuerpos monoclonales IOR y se identificaron las poblaciones de celulas mononucleares presentes en el infiltrado reaccional de los carcinomas basocelular y epidermoide de piel. Se comparo la composicion celular del infiltrado reacional entre estos carcinomas, se encontraron diferencias significativas en el comportamiento de lapoblacion de linfocitos T CD6+ y de monocitos y macrofagos. Por los resultados obtenidos se explica como pudieran influir en el comportamiento biologico de estos tumores


Subject(s)
Antibodies, Monoclonal , Carcinoma, Squamous Cell/enzymology , Carcinoma, Squamous Cell/immunology , Carcinoma, Basal Cell/enzymology , Carcinoma, Basal Cell/immunology , In Vitro Techniques , Skin Neoplasms/enzymology , Skin Neoplasms/immunology
11.
Journal of Korean Medical Science ; : 97-102, 1995.
Article in English | WPRIM | ID: wpr-64333

ABSTRACT

Expression of nucleoside diphosphate(NDP) kinase, which is homologous to the nm23 gene product in a variety of species, has been found to be inversely associated with metastatic potential. However, the relationship remains controversial according to the tumor cell types and experimental system, with conflicting results from different research groups. In order to determine whether NDP kinase expression serves as a marker for metastatic potential in human skin cancer, we assessed the levels of NDP kinase expression in 9 keratoacanthomas (KAs), 26 squamous cell carcinomas (SCCs), and 25 basal cell carcinomas (BCCs) using immunohistochemistry. The expression of NDP kinase was intense in KA and SCC compared with BCC. However, the difference of NDP kinase expression between KA and SCC was not statistically significant. And there was no statistically significant difference in NDP kinase expression between SCC with metastasis and SCC without metastasis. Our results contradict the hypothesis concerning the possible role of nm23 gene as a metastatic suppressor gene in human skin cancer. The mechanism of overexpression in various tumor cell types and its biological significance in cutaneous carcinogenesis remain to be determined.


Subject(s)
Humans , Antibodies, Monoclonal , Carcinoma, Basal Cell/enzymology , Carcinoma, Squamous Cell/enzymology , Comparative Study , Erythrocytes/enzymology , Immunohistochemistry , Keratoacanthoma/enzymology , Nucleoside-Diphosphate Kinase/analysis , Skin Diseases/enzymology , Skin Neoplasms/enzymology , Transcription Factors/analysis
SELECTION OF CITATIONS
SEARCH DETAIL